$314 Million is the total value of Knott David M Jr's 180 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 110.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CLMT | Buy | Calumet Specialty Products Partners, LP | $59,782,000 | +14.6% | 4,392,500 | +11.1% | 19.04% | +7.5% |
| New | Apollo Global Management, Inc. | $15,498,000 | – | 250,000 | +100.0% | 4.94% | – | |
| Buy | DocGo, Inc. | $12,950,000 | +29.4% | 1,400,000 | +30.8% | 4.12% | +21.4% | |
| LGND | Buy | Ligand Pharmaceuticals Incorporated | $12,937,000 | +11.7% | 115,000 | +53.3% | 4.12% | +4.8% |
| PFE | Buy | Pfizer | $7,429,000 | +20.4% | 143,500 | +37.3% | 2.37% | +12.9% |
| VXX | New | Ipath Series B S&P 500 Short Term Future | $6,425,000 | – | 250,000 | +100.0% | 2.05% | – |
| MDWT | Buy | Midwest Holding Inc. | $4,923,000 | +14.9% | 293,937 | +20.5% | 1.57% | +7.8% |
| JNJ | Buy | Johnson & Johnson | $4,395,000 | +542.5% | 24,800 | +520.0% | 1.40% | +503.4% |
| HZNP | Buy | Horizon Therapeutics Public Ltd. Company | $3,525,000 | +72.2% | 33,490 | +76.3% | 1.12% | +61.6% |
| INCY | Buy | Incyte Corporation | $3,480,000 | +10.7% | 43,820 | +2.3% | 1.11% | +3.8% |
| ABBV | Buy | Abbvie Inc. | $3,249,000 | +140.0% | 20,037 | +100.4% | 1.04% | +125.0% |
| EIGR | Buy | Eiger BioPharmaceuticals, Inc. | $3,231,000 | +96.1% | 389,292 | +22.6% | 1.03% | +84.1% |
| BIP | New | Brookfield Infrastructure Partners | $2,980,000 | – | 45,000 | +100.0% | 0.95% | – |
| JPM | Buy | JP Morgan Chase | $2,756,000 | +34.7% | 20,220 | +56.5% | 0.88% | +26.3% |
| CTIC | Buy | CTI BioPharma Corp. | $2,600,000 | +374.5% | 556,687 | +151.8% | 0.83% | +345.2% |
| RHP | Buy | Ryman Hospitality Ppty Inc. | $2,263,000 | +98.3% | 24,400 | +96.8% | 0.72% | +86.3% |
| BBIO | New | Bridgebio Pharma, Inc. | $2,039,000 | – | 200,893 | +100.0% | 0.65% | – |
| MRK | Buy | Merck & Co Inc. | $2,010,000 | +1930.3% | 24,500 | +1784.6% | 0.64% | +1782.4% |
| SRRA | New | Sierra Oncology | $1,787,000 | – | 55,758 | +100.0% | 0.57% | – |
| RDUS | New | Radius Health Inc. | $1,574,000 | – | 178,218 | +100.0% | 0.50% | – |
| CHRS | Buy | Coherus Biosciences, Inc. | $1,518,000 | -7.3% | 117,555 | +14.6% | 0.48% | -13.1% |
| AUPH | New | Aurinia Pharmaceuticals Inc. | $999,000 | – | 80,694 | +100.0% | 0.32% | – |
| WPC | Buy | WP Carey | $970,000 | +97.2% | 12,000 | +100.0% | 0.31% | +85.0% |
| PCYO | New | Purecycle Corp | $962,000 | – | 80,000 | +100.0% | 0.31% | – |
| BHVN | New | Biohaven Pharmaceutical Holding Co. Ltd | $931,000 | – | 7,851 | +100.0% | 0.30% | – |
| CCOI | New | Cogent Communications Holdings | $929,000 | – | 14,000 | +100.0% | 0.30% | – |
| VZ | Buy | Verizon Communcations | $917,000 | +3.9% | 17,991 | +5.9% | 0.29% | -2.7% |
| LQDA | Buy | Liquidia Corporation | $770,000 | +112.7% | 107,260 | +44.3% | 0.24% | +99.2% |
| GMED | Buy | Globus Medical, Inc. | $762,000 | +128.1% | 10,331 | +123.1% | 0.24% | +115.0% |
| FNB | Buy | FNB Bancorp | $741,000 | +586.1% | 59,485 | +568.0% | 0.24% | +537.8% |
| VKTX | Buy | Viking Therapeutics, Inc. | $684,000 | -28.5% | 228,102 | +9.6% | 0.22% | -32.9% |
| HVBC | New | HV Bancorp | $543,000 | – | 25,000 | +100.0% | 0.17% | – |
| IOVA | Buy | Iovance Biotherapeutics, Inc. | $510,000 | +33.5% | 30,614 | +52.9% | 0.16% | +24.6% |
| CDTX | Buy | Cidara Therapeutics, Inc. | $482,000 | -11.6% | 579,154 | +35.0% | 0.15% | -16.8% |
| VLY | Buy | Valley National Bancorp | $417,000 | +215.9% | 32,000 | +233.3% | 0.13% | +195.6% |
| IGT | Buy | International Gaming Technologies | $407,000 | +87.6% | 16,500 | +120.0% | 0.13% | +75.7% |
| PBCT | Buy | Peoples United Financial | $390,000 | +1344.4% | 19,500 | +1200.0% | 0.12% | +1277.8% |
| New | QualTek Services Inc. WTS | $288,000 | – | 25,000 | +100.0% | 0.09% | – | |
| MGTX | New | MeiraGTx Holding plc | $277,000 | – | 20,000 | +100.0% | 0.09% | – |
| RY | New | Royal Bank Canada | $276,000 | – | 2,500 | +100.0% | 0.09% | – |
| MTB | New | M&T Bancorp | $203,000 | – | 1,199 | +100.0% | 0.06% | – |
| LW | New | Lamb West Holdings Inc. | $200,000 | – | 3,333 | +100.0% | 0.06% | – |
| IVV | New | Ishares Core S&P ETF S&P 500 index | $195,000 | – | 429 | +100.0% | 0.06% | – |
| NEM | New | Newmont Corporation | $159,000 | – | 2,000 | +100.0% | 0.05% | – |
| NWBI | New | Northwest Bancshares Inc. | $135,000 | – | 10,000 | +100.0% | 0.04% | – |
| SPY | New | SPDR S&P 500 ETF | $113,000 | – | 250 | +100.0% | 0.04% | – |
| OGN | Buy | Organon & Co. | $86,000 | +4200.0% | 2,450 | +2962.5% | 0.03% | +2600.0% |
| ETTX | New | Entasis Therapeutics Holding | $78,000 | – | 41,700 | +100.0% | 0.02% | – |
| TGNA | New | Tegna Inc. | $67,000 | – | 3,000 | +100.0% | 0.02% | – |
| LPTX | New | Leap Therapeutics, Inc. | $44,000 | – | 25,100 | +100.0% | 0.01% | – |
| MIC | New | Macquire Infrastructure Corp | $39,000 | – | 10,350 | +100.0% | 0.01% | – |
| New | General Electric | $29,000 | – | 312 | +100.0% | 0.01% | – | |
| EXP | Buy | Eagle Materials | $29,000 | -23.7% | 288 | +26.3% | 0.01% | -30.8% |
| IJR | New | Ishares Core S&P ETF Small Cap | $21,000 | – | 197 | +100.0% | 0.01% | – |
| RSP | New | Invesco Trust ETF S&P 500 Equal Weight RSP | $15,000 | – | 96 | +100.0% | 0.01% | – |
| RMR | Buy | RMR Group Inc. | $12,000 | +1100.0% | 414 | +2487.5% | 0.00% | – |
| GM | New | General Motors | $12,000 | – | 275 | +100.0% | 0.00% | – |
| VNQ | New | Vanguard Index Real Estate | $8,000 | – | 74 | +100.0% | 0.00% | – |
| RPV | New | Invesco Trust ETF S&P 500 Equal Weight pure Value | $7,000 | – | 78 | +100.0% | 0.00% | – |
| PG | New | Proctor & Gamble | $5,000 | – | 35 | +100.0% | 0.00% | – |
| ABT | New | Abbott Labs | $6,000 | – | 50 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Calumet Specialty Products Partners, LP | 8 | Q3 2023 | 31.5% |
| Alphabet Inc-Cl C | 8 | Q3 2023 | 5.6% |
| DocGo, Inc. | 8 | Q3 2023 | 5.8% |
| Ligand Pharmaceuticals Incorporated | 8 | Q3 2023 | 4.3% |
| Franklin BSP Realty Trust, Inc. | 8 | Q3 2023 | 4.9% |
| Midwest Holding Inc. | 8 | Q3 2023 | 4.1% |
| Coliseum Acquisition Corp.WTS | 8 | Q3 2023 | 2.4% |
| Pfizer Inc. | 8 | Q3 2023 | 3.2% |
| Jazz Pharmaceuticals PLC | 8 | Q3 2023 | 1.5% |
| Vertex Pharmaceuticals, Inc. | 8 | Q3 2023 | 2.1% |
View Knott David M Jr's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Calumet Specialty Products Partners, L.P. | November 08, 2021 | 4,292,200 | 5.4% |
View Knott David M Jr's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 4 | 2023-12-22 |
| SC 13D/A | 2023-12-22 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-10 |
| 4 | 2022-09-26 |
| 4 | 2022-09-02 |
View Knott David M Jr's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.